{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:42Z","timestamp":1786980522334,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-025-04483-y","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:29:23Z","timestamp":1747898963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A systematic review of erbium lasers in the treatment of androgenetic alopecia"],"prefix":"10.1007","volume":"40","author":[{"given":"Mohammad Ali","family":"Nilforoushzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Fathabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Ghanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Najar Nobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"4483_CR1","unstructured":"Piraccini BM, Alessandrini A. Androgenetic alopecia. (0392\u20130488 (Print))."},{"issue":"3","key":"4483_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","volume":"53","author":"JB Hamilton","year":"1951","unstructured":"Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53(3):708\u2013728. https:\/\/doi.org\/10.1111\/j.1749-6632.1951.tb31971.x","journal-title":"Ann N Y Acad Sci"},{"key":"4483_CR3","unstructured":"Krausz A Fau - Friedman AJ, Friedman AJ. Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia. (1545\u20139616 (Print))."},{"issue":"2","key":"4483_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0738-081x(00)00125-5","volume":"19","author":"JA Ellis","year":"2001","unstructured":"Ellis JA, Harrap SB (2001) The genetics of androgenetic alopecia. Clin Dermatol 19(2):149\u2013154. https:\/\/doi.org\/10.1016\/s0738-081x(00)00125-5","journal-title":"Clin Dermatol"},{"issue":"5","key":"4483_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.clinthera.2020.03.008","volume":"42","author":"N Pondeljak","year":"2020","unstructured":"Pondeljak N, Lugovic-Mihic L (2020) Stress-induced Interaction of Skin Immune Cells, Hormones, and Neurotransmitters. Clin Ther 42(5):757\u2013770. https:\/\/doi.org\/10.1016\/j.clinthera.2020.03.008","journal-title":"Clin Ther"},{"issue":"1","key":"4483_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5826\/dpc.0701a01","volume":"7","author":"EL Guo","year":"2017","unstructured":"Guo EL, Katta R (2017) Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatol Pract Concept 7(1):1\u201310. https:\/\/doi.org\/10.5826\/dpc.0701a01","journal-title":"Dermatol Pract Concept"},{"key":"4483_CR7","doi-asserted-by":"publisher","unstructured":"Peyravian N, Deo S, Daunert S, Jimenez JJ. (2020) The Inflammatory Aspect of Male and Female Pattern Hair Loss. J Inflamm Res 13(1178\u20137031 (Print)):879\u201381. https:\/\/doi.org\/10.2147\/JIR.S275785.","DOI":"10.2147\/JIR.S275785"},{"issue":"2","key":"4483_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/npmj.npmj_47_24","volume":"31","author":"SO Oiwoh","year":"2024","unstructured":"Oiwoh SO, Enitan AO, Adegbosin OT, Akinboro AO, Onayemi EO (2024) Androgenetic Alopecia: A Review. Niger Postgrad Med J 31(2):85\u201392. https:\/\/doi.org\/10.4103\/npmj.npmj_47_24","journal-title":"Niger Postgrad Med J"},{"issue":"1","key":"4483_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","volume":"164","author":"U Blume-Peytavi","year":"2011","unstructured":"Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M et al (2011) S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 164(1):5\u201315. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10011.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"4483_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1087-0024.2005.10102.x","volume":"10","author":"DC Gan","year":"2005","unstructured":"Gan DC, Sinclair RD (2005) Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc 10(3):184\u2013189. https:\/\/doi.org\/10.1111\/j.1087-0024.2005.10102.x","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"12","key":"4483_CR11","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.14537","volume":"20","author":"MS Nestor","year":"2021","unstructured":"Nestor MS, Ablon G, Gade A, Han H, Fischer DL (2021) Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol 20(12):3759\u20133781. https:\/\/doi.org\/10.1111\/jocd.14537","journal-title":"J Cosmet Dermatol"},{"key":"4483_CR12","unstructured":"Salisbury BH, Leslie SW, Tadi P. 5\u03b1-Reductase Inhibitors. BTI - StatPearls."},{"key":"4483_CR13","unstructured":"Patel P Fau - Nessel TA, Nessel TA, Kumar DD. Minoxidil. BTI - StatPearls."},{"issue":"1","key":"4483_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijwd.2018.08.004","volume":"5","author":"J Stevens","year":"2019","unstructured":"Stevens J, Khetarpal S (2019) Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. Int J Womens Dermatol 5(1):46\u201351. https:\/\/doi.org\/10.1016\/j.ijwd.2018.08.004","journal-title":"Int J Womens Dermatol"},{"key":"4483_CR15","doi-asserted-by":"publisher","unstructured":"Li Y, Wang G, Wang Q, Zhang Y, Cui L, Huang X. (2022) Exosomes Secreted from Adipose-Derived Stem Cells Are a Potential Treatment Agent for Immune-Mediated Alopecia. J Immunol Res 2022(2314\u20137156 (Electronic)):7471246. https:\/\/doi.org\/10.1155\/2022\/7471246.","DOI":"10.1155\/2022\/7471246"},{"issue":"3","key":"4483_CR16","first-page":"205","volume":"12","author":"A Tosti","year":"1999","unstructured":"Tosti A, Camacho-Martinez F, Dawber R (1999) Management of androgenetic alopecia. J Eur Acad Dermatol Venereol 12(3):205\u2013214","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4483_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10103-024-04054-7","volume":"39","author":"P Jean-Pierre","year":"2024","unstructured":"Jean-Pierre P, Pulumati A, Kasheri E, Hirsch M, Nouri K (2024) Lasers in the management of alopecia: a review of established therapies and advances in treatment. Lasers Med Sci 39(1):102. https:\/\/doi.org\/10.1007\/s10103-024-04054-7","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4483_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X et al (2022) Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7(1):3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal Transduct Target Ther"},{"key":"4483_CR19","unstructured":"Day DA-OX, McCarthy MA-O, Talaber IA-O. Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia. (1473\u20132165 (Electronic))."},{"key":"4483_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"4483_CR21","unstructured":"National Heart L, and Blood Institute (2014). Quality Assessment of Clinical trials. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"4483_CR22","unstructured":"National Heart L, and Blood Institute (2014). Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"4483_CR23","unstructured":"L. National Heart aBI. (2014) Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"4483_CR24","unstructured":"L. National Heart aBI (2014). NIH Quality Assessment of Case series. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"issue":"2","key":"4483_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid Based Med"},{"key":"4483_CR26","doi-asserted-by":"publisher","unstructured":"Haddad N, Arruda S, Sadick N. (2022) Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia. J Drugs Dermatol 21(11):1166\u20139. https:\/\/doi.org\/10.36849\/JDD.6750.","DOI":"10.36849\/JDD.6750"},{"issue":"4","key":"4483_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/jocd.13122","volume":"19","author":"MK Alhattab","year":"2020","unstructured":"Alhattab MK, Al Abdullah MJ, Al-Janabi MH, Aljanaby WA, Alwakeel HA (2020) The effect of 1540-nm fractional erbium-glass laser in the treatment of androgenic alopecia. J Cosmet Dermatol 19(4):878\u2013883. https:\/\/doi.org\/10.1111\/jocd.13122","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"4483_CR28","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10103-019-02783-8","volume":"34","author":"P Suchonwanit","year":"2019","unstructured":"Suchonwanit P, Rojhirunsakool S, Khunkhet S (2019) A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. Lasers Med Sci 34(9):1857\u20131864. https:\/\/doi.org\/10.1007\/s10103-019-02783-8","journal-title":"Lasers Med Sci"},{"issue":"10","key":"4483_CR29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/DSS.0000000000001619","volume":"44","author":"J Meephansan","year":"2018","unstructured":"Meephansan J, Ungpraphakorn N, Ponnikorn S, Suchonwanit P, Poovorawan Y (2018) Efficacy of 1,550-nm Erbium-Glass Fractional Laser Treatment and Its Effect on the Expression of Insulin-Like Growth Factor 1 and Wnt\/beta-Catenin in Androgenetic Alopecia. Dermatol Surg 44(10):1295\u20131303. https:\/\/doi.org\/10.1097\/DSS.0000000000001619","journal-title":"Dermatol Surg"},{"issue":"1","key":"4483_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1524-4725.2010.01833.x","volume":"37","author":"WS Kim","year":"2011","unstructured":"Kim WS, Lee HI, Lee JW, Lim YY, Lee SJ, Kim BJ et al (2011) Fractional photothermolysis laser treatment of male pattern hair loss. Dermatol Surg 37(1):41\u201351. https:\/\/doi.org\/10.1111\/j.1524-4725.2010.01833.x","journal-title":"Dermatol Surg"},{"issue":"12","key":"4483_CR31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1468-3083.2011.04183.x","volume":"25","author":"GY Lee","year":"2011","unstructured":"Lee GY, Lee SJ, Kim WS (2011) The effect of a 1550 nm fractional erbium-glass laser in female pattern hair loss. J Eur Acad Dermatol Venereol 25(12):1450\u20131454. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04183.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"4483_CR32","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/jocd.15955","volume":"22","author":"F Mokhtari","year":"2023","unstructured":"Mokhtari F, Zavare Z, Iraji F (2023) Topical 5% minoxidil versus combined erbium YAG laser and topical 5% minoxidil in androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol 22(10):2737\u20132743. https:\/\/doi.org\/10.1111\/jocd.15955","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"4483_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1046\/j.1524-4725.2001.01033.x","volume":"27","author":"NS Sadick","year":"2001","unstructured":"Sadick NS, Shea CR, Nicholson J, Gat M, Lunievski S, Prieto VG (2001) A comparative clinical and histologic study of hair transplantation using Er:YAG, Er:YAG\/CO2, and standard punch techniques. Dermatol Surg 27(9):807\u2013812. https:\/\/doi.org\/10.1046\/j.1524-4725.2001.01033.x","journal-title":"Dermatol Surg"},{"key":"4483_CR34","doi-asserted-by":"publisher","unstructured":"Azimova FV, Zakirov RR, Nurmatova IB. (2022) Erbium YAG Laser in the Treatment of Androgenetic Alopecia. Int J Biomed 12(2):269\u201372. https:\/\/doi.org\/10.21103\/Article12(2)_OA12.","DOI":"10.21103\/Article12(2)_OA12"},{"issue":"5","key":"4483_CR35","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/jocd.14370","volume":"21","author":"D Day","year":"2022","unstructured":"Day D, McCarthy M, Talaber I (2022) Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia. J Cosmet Dermatol 21(5):2056\u20132063. https:\/\/doi.org\/10.1111\/jocd.14370","journal-title":"J Cosmet Dermatol"},{"issue":"11","key":"4483_CR36","doi-asserted-by":"publisher","first-page":"e15801","DOI":"10.1111\/dth.15801","volume":"35","author":"YP Su","year":"2022","unstructured":"Su YP, Wu XJ (2022) Ablative 2940 nm Er: YAG fractional laser for male androgenetic alopecia. Dermatol Ther 35(11):e15801. https:\/\/doi.org\/10.1111\/dth.15801","journal-title":"Dermatol Ther"},{"key":"4483_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.maturitas.2023.04.261","volume":"173","author":"B Dekeyser","year":"2023","unstructured":"Dekeyser B, Wellens M, Talaber I (2023) Non-ablative Er:YAG-laser treatment improves quality of life in menopausal female pattern hair loss. Maturitas 173:116\u2013117. https:\/\/doi.org\/10.1016\/j.maturitas.2023.04.261","journal-title":"Maturitas"},{"issue":"11","key":"4483_CR38","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","volume":"68","author":"OT Norwood","year":"1975","unstructured":"Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68(11):1359\u20131365. https:\/\/doi.org\/10.1097\/00007611-197511000-00009","journal-title":"South Med J"},{"key":"4483_CR39","doi-asserted-by":"publisher","unstructured":"Cuevas-Diaz Duran R, Martinez-Ledesma E, Garcia-Garcia M, Bajo Gauzin D, Sarro-Ramirez A, Gonzalez-Carrillo C, et al. (2024) The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia. Int J Mol Sci 25(5). https:\/\/doi.org\/10.3390\/ijms25052542.","DOI":"10.3390\/ijms25052542"},{"issue":"2","key":"4483_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/cdr.cdr_29_21","volume":"6","author":"A Kidangazhiathmana","year":"2022","unstructured":"Kidangazhiathmana A, Santhosh P (2022) Pathogenesis of androgenetic alopecia. Clinical Dermatology Review 6(2):69\u201374. https:\/\/doi.org\/10.4103\/cdr.cdr_29_21","journal-title":"Clinical Dermatology Review"},{"issue":"1","key":"4483_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jdv.14624","volume":"32","author":"V Kanti","year":"2018","unstructured":"Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A et al (2018) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol 32(1):11\u201322. https:\/\/doi.org\/10.1111\/jdv.14624","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4483_CR42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/CCID.S385861","volume":"16","author":"M Kaiser","year":"2023","unstructured":"Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ (2023) Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clin Cosmet Investig Dermatol 16:1387\u20131406. https:\/\/doi.org\/10.2147\/CCID.S385861","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"10","key":"4483_CR43","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4065\/80.10.1316","volume":"80","author":"D Stough","year":"2005","unstructured":"Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA et al (2005) Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 80(10):1316\u20131322. https:\/\/doi.org\/10.4065\/80.10.1316","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"4483_CR44","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1523-1747.2003.12615.x","volume":"121","author":"DR Nyholt","year":"2003","unstructured":"Nyholt DR, Gillespie NA, Heath AC, Martin NG (2003) Genetic basis of male pattern baldness. J Invest Dermatol 121(6):1561\u20131564. https:\/\/doi.org\/10.1111\/j.1523-1747.2003.12615.x","journal-title":"J Invest Dermatol"},{"issue":"4","key":"4483_CR45","first-page":"319","volume":"10","author":"R Hoffmann","year":"2000","unstructured":"Hoffmann R, Happle R (2000) Current understanding of androgenetic alopecia. Part I: etiopathogenesis Eur J Dermatol 10(4):319\u2013327","journal-title":"Part I: etiopathogenesis Eur J Dermatol"},{"issue":"3 Suppl","key":"4483_CR46","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1067\/mjd.2001.117426","volume":"45","author":"EA Olsen","year":"2001","unstructured":"Olsen EA (2001) Female pattern hair loss. J Am Acad Dermatol 45(3 Suppl):S70-80. https:\/\/doi.org\/10.1067\/mjd.2001.117426","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4483_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0738-081x(00)00128-0","volume":"19","author":"RD Sinclair","year":"2001","unstructured":"Sinclair RD, Dawber RP (2001) Androgenetic alopecia in men and women. Clin Dermatol 19(2):167\u2013178. https:\/\/doi.org\/10.1016\/s0738-081x(00)00128-0","journal-title":"Clin Dermatol"},{"issue":"8","key":"4483_CR48","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/dsu.12200","volume":"39","author":"H Kim","year":"2013","unstructured":"Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH (2013) Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg 39(8):1177\u20131183. https:\/\/doi.org\/10.1111\/dsu.12200","journal-title":"Dermatol Surg"},{"issue":"3","key":"4483_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5999\/aps.2012.39.3.232","volume":"39","author":"SG Kim","year":"2012","unstructured":"Kim SG, Kim EY, Kim YJ, Lee SI (2012) The Efficacy and Safety of Ablative Fractional Resurfacing Using a 2,940-Nm Er:YAG Laser for Traumatic Scars in the Early Posttraumatic Period. Arch Plast Surg 39(3):232\u2013237. https:\/\/doi.org\/10.5999\/aps.2012.39.3.232","journal-title":"Arch Plast Surg"},{"issue":"3","key":"4483_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jconrel.2008.03.003","volume":"128","author":"WR Lee","year":"2008","unstructured":"Lee WR, Pan TL, Wang PW, Zhuo RZ, Huang CM, Fang JY (2008) Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J Control Release 128(3):200\u2013208. https:\/\/doi.org\/10.1016\/j.jconrel.2008.03.003","journal-title":"J Control Release"},{"issue":"4","key":"4483_CR51","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1101\/gad.1614408","volume":"22","author":"M Rendl","year":"2008","unstructured":"Rendl M, Polak L, Fuchs E (2008) BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev 22(4):543\u2013557. https:\/\/doi.org\/10.1101\/gad.1614408","journal-title":"Genes Dev"},{"key":"4483_CR52","doi-asserted-by":"publisher","first-page":"730139","DOI":"10.1155\/2015\/730139","volume":"2015","author":"WH Lin","year":"2015","unstructured":"Lin WH, Xiang LJ, Shi HX, Zhang J, Jiang LP, Cai PT et al (2015) Fibroblast growth factors stimulate hair growth through beta-catenin and Shh expression in C57BL\/6 mice. Biomed Res Int 2015:730139. https:\/\/doi.org\/10.1155\/2015\/730139","journal-title":"Biomed Res Int"},{"key":"4483_CR53","doi-asserted-by":"crossref","unstructured":"Cohen PR. (2019) Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma - with or without concurrent bimatoprost and\/or minoxidil. Dermatol Online J 25(2).","DOI":"10.5070\/D3252042885"},{"issue":"4","key":"4483_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1515\/plm-2013-0028","volume":"2","author":"Y Li","year":"2013","unstructured":"Li Y, Guo L, Lu W (2013) Laser ablation-enhanced transdermal drug delivery. Laserablations-verst\u00e4rkte transdermale Medikamentenverabreichung 2(4):315\u2013322. https:\/\/doi.org\/10.1515\/plm-2013-0028","journal-title":"Laserablations-verst\u00e4rkte transdermale Medikamentenverabreichung"},{"issue":"1","key":"4483_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/ijt.ijt_75_16","volume":"9","author":"KB Shah","year":"2017","unstructured":"Shah KB, Shah AN, Solanki RB, Raval RC (2017) A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia. Int J Trichology 9(1):14\u201318. https:\/\/doi.org\/10.4103\/ijt.ijt_75_16","journal-title":"Int J Trichology"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04483-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:22:36Z","timestamp":1771399356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04483-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04483-y","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare there is no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}